ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ANNX Annexon Inc

4.65
0.20 (4.49%)
After Hours
Last Updated: 16:43:30
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Annexon Inc ANNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.20 4.49% 4.65 16:43:30
Open Price Low Price High Price Close Price Prev Close
4.37 4.26 4.83 4.59 4.45
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/16/202409:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
2/21/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202415:15EDGAR2Form 144 - Report of proposed sale of securities
2/20/202415:12EDGAR2Form 144 - Report of proposed sale of securities
2/14/202420:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202419:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202418:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202415:45EDGAR2Form 144 - Report of proposed sale of securities
2/12/202415:41EDGAR2Form 144 - Report of proposed sale of securities
2/12/202415:39EDGAR2Form 144 - Report of proposed sale of securities
1/23/202417:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
1/23/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:09EDGAR2Form 8-K - Current report
1/07/202420:00GLOBEAnnexon Outlines 2024 Priorities with Late-Stage Clinical..
12/29/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202316:50EDGAR2Form 144 - Report of proposed sale of securities
12/27/202306:30GLOBEAnnexon Biosciences to Present at the 42nd Annual J.P...
12/22/202317:28EDGAR2Form 8-K/A - Current report: [Amend]
12/21/202316:09EDGAR2Form 8-K - Current report
12/21/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/20/202317:27GLOBEAnnexon Announces Pricing of $125.0 Million Underwritten..
12/20/202317:24EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
12/20/202317:17EDGAR2Form 8-K - Current report
12/20/202317:10GLOBEAnnexon Outlines Global Registrational Program for ANX007 in..
12/20/202317:08GLOBEAnnexon Reports Phase 1 Results for ANX1502, its Oral Small..
12/18/202316:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
11/22/202316:01GLOBEAnnexon Biosciences to Participate in the 6th Annual..
11/13/202316:10EDGAR2Form 8-K - Current report
11/13/202306:30GLOBEAnnexon Reports Significant Progress with its Priority..
11/09/202306:30GLOBEAnnexon Biosciences to Participate in 2023 Jefferies London..
10/24/202316:30EDGAR2Form 8-K - Current report
10/24/202306:30GLOBEAnnexon Receives PRIME Designation from the EMA for ANX007..
10/18/202316:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
10/11/202316:44EDGAR2Form 8-K - Current report
10/10/202306:30GLOBEAnnexon Announces Clinical and Regulatory Progress for..
9/19/202306:30GLOBEAnnexon Biosciences to Participate in the 2023 Cantor Global..
9/18/202316:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..
8/07/202316:12EDGAR2Form 8-K - Current report
8/07/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202306:30GLOBEAnnexon Highlights Recent Pipeline and Business Progress and..
8/02/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202317:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/02/202316:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..

Your Recent History

Delayed Upgrade Clock